Ocrevus (ocrelizumab) - Roche
fingolimod - Generic mfg.
Errate: Nasal Mucociliary Clearance and Its Relationship With Disease Severity in Patients With Multiple Sclerosis. (PubMed, Med Sci Monit) - Sep 16, 2026 - "In the published version of Figure 2, the bars representing the Ocrelizumab and Fingolimod treatment groups were inadvertently interchanged. 2026; 32:e952850. DOI: 10.12659/MSM.952850." 
Journal • CNS Disorders • Multiple Sclerosis
http://www.ncbi.nlm.nih.gov/pubmed/42740694
 
Caner Baydar; Yaser Said Cetin
 
Sep 16, 2026
 
Prev Next